HIVE (HIVE) director sells 175,000 shares, keeps unvested RSUs vesting through 2027
Rhea-AI Filing Summary
HIVE Digital Technologies director Dave Perrill reported a net sale of shares. On June 19, 2026 he sold 175,000 common shares in open-market transactions, leaving no common shares directly owned after the sale. Earlier, on May 7, 2026, he exercised previously granted restricted share units (RSUs) that converted into common shares on a one-for-one basis under the company’s Restricted Share Unit Plan. Footnotes show RSUs that vested and were settled into common stock on May 7, 2026, as well as additional RSU awards that remain unvested and are scheduled to vest in installments through March 16, 2027.
Positive
- None.
Negative
- None.
Insights
Director fully liquidates current shares but still holds future RSUs.
Director Dave Perrill sold 175,000 HIVE Digital Technologies common shares in open-market trades on June 19, 2026, reducing his directly held common share balance to zero. This followed the May 7, 2026 conversion of RSUs into common shares.
The filing also details RSU grants that vested and converted on May 7, 2026, plus additional RSU awards that will vest in stages on August 5, 2026, November 5, 2026, July 8, 2026, October 31, 2026 and March 16, 2027. These represent future equity that will convert into common shares when vesting conditions are met.
Because the sale size is not compared to the company’s total shares outstanding, the broader impact is hard to gauge from this filing alone. The key takeaway is a complete sale of current direct common holdings, offset by a pipeline of unvested RSUs scheduled to vest over the next several disclosed dates.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares | 175,000 | $4.69 | $821K |
| Exercise | Restricted stock units | 100,000 | $0.00 | -- |
| Exercise | Restricted stock units | 12,500 | $0.00 | -- |
| Exercise | Common Shares | 100,000 | $0.00 | -- |
| Exercise | Common Shares | 12,500 | $0.00 | -- |
Footnotes (1)
- Reflects restricted share units ("RSUs") issued pursuant to the Issuer's Restricted Share Unit Plan (the "RSU Plan") that, upon vesting and settlement converted into shares of Issuer common stock on a one-for-one basis. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from C$6.589 to C$6.660, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The weighted average price reported above was converted from the Canadian weighted average price of C$6.639 to USD$4.57, using an exchange rate of USD$1.00 = C$0.705, as reported by the Bank of Canada on June 19, 2026. Reflects 100,000 RSUs that were awarded on April 17, 2025 and vested on April 17, 2026. These RSUs were settled and converted into common shares of the Issuer on May 7, 2026, in accordance with the Issuer's RSU Plan. Reflects 12,500 RSUs that were awarded on November 5, 2024 and vested on May 5, 2026. These RSUs were settled and converted into common shares of the Issuer on May 7, 2026, in accordance with the Issuer's RSU Plan. Reflects additional RSU awards that have not vested and converted that were previously reported. The underlying shares and vesting schedules are as follows: (i) 25,000 vest in two equal installments of 12,500 on each of August 5, 2026 and November 5, 2026; (ii) 100,000 will vest on July 8, 2026; (iii) 100,000 will vest on October 31, 2026 and (iv) 100,000 will vest on March 16, 2027.